98%
921
2 minutes
20
Background: Heart failure (HF) is a substantial public health concern associated with poor prognosis and limited tools for early prediction. Arterial stiffness contributes to the development of HF, particularly with a preserved ejection fraction. The cardio-ankle vascular index (CAVI) is a noninvasive, pressure-independent marker of arterial stiffness. However, its prognostic value in HF remains unclear.
Objective: We aimed to evaluate whether CAVI independently predicts HF-related hospitalizations in patients with cardiovascular risk factors and whether it adds prognostic value beyond conventional risk factors.
Methods: This sub-analysis of the multicenter prospective CAVI-J study included 2,932 Japanese adults aged 40-74 years with cardiovascular risk factors. Participants were stratified into CAVI tertiles and followed up for a median of 4.9 years. The primary outcomes were HF-related hospitalizations and cardiovascular death. Cox proportional hazards models were used to assess the risk, and the incremental prognostic value was evaluated using global chi-squared statistics and reclassification indices.
Results: Primary outcomes were recorded in 32 patients (1.1%). High CAVI (≥9.0) was independently associated with increased risk (hazard ratio 3.18, 95% confidence interval: 1.09-9.31; P = 0.034). When CAVI was added to a model with known conventional risks, the global chi value increased from 8.82 to 18.77 (P = 0.002), and the net reclassification index was 0.621 (P < 0.001).
Conclusions: Elevated CAVI independently associated with HF-related hospitalizations and cardiovascular death and modestly improved risk prediction beyond conventional risk factors. However, the discriminative ability remained limited, and further studies are warranted to establish its clinical utility.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jacadv.2025.102187 | DOI Listing |
ESC Heart Fail
September 2025
Department of Medicine, Division of Cardiology, Queen Elizabeth Hospital, Hong Kong, Hong Kong.
Aims: Despite therapeutic advancements, the prognosis of heart failure (HF) remains poor, with high rates of mortality and readmission, particularly following a HF exacerbation. This study aimed to evaluate the effects of a nurse-coordinated multidisciplinary comprehensive HF management programme on HF patients.
Methods And Results: This retrospective cohort study involved patients admitted for acute HF exacerbation at a regional hospital in Hong Kong.
This systematic review evaluates the cardiovascular effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in adults with type 2 diabetes mellitus (T2DM) and established atherosclerotic cardiovascular disease, chronic kidney disease, or heart failure (HF). A comprehensive literature search across four major databases identified eight eligible studies, including randomized controlled trials and prespecified or pooled post-hoc analyses. The findings demonstrate consistent cardiovascular benefits of GLP-1 RAs, particularly semaglutide and exenatide, with notable reductions in major adverse cardiovascular events, cardiovascular mortality, and HF-related outcomes.
View Article and Find Full Text PDFEur J Heart Fail
September 2025
Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Aims: The estimated glucose disposal rate (eGDR) is a simple, non-invasive measure of insulin resistance. In this exploratory analysis of FINEARTS-HF, we evaluated whether lower eGDR, reflecting greater insulin resistance, is associated with adverse outcomes in heart failure (HF).
Methods And Results: The eGDR was calculated at baseline using waist circumference, glycated haemoglobin, and hypertension status.
Herz
September 2025
Universitätsklinik für Herzchirurgie, Herzzentrum Leipzig, Leipzig, Deutschland.
In recent years the treatment for heart failure (HF) has become much more complex. This development has highlighted the importance of a multidisciplinary HF team to ensure the best possible individually adapted treatment decisions, taking the patient's personal wishes into account and to achieve optimal results. In Germany, specialized HF practices, clinics and tertiary bespoke HF unit centers were established to ensure qualified care for HF patients.
View Article and Find Full Text PDFESC Heart Fail
September 2025
Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Aims: Protein glycosylation regulated by glycosyltransferases is an important type of post-translational modification. The role of the glycosyltransferase genes (GTGs) in heart failure (HF) remains unclear and requires further investigation.
Methods: Differential expression analysis was performed on the transverse aortic constriction (TAC)-related dataset GSE36074 to screen out the differentially expressed GTGs.